Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • COVID-19 impact
  • Reproductive Health Impact Study
  • IPSRH: Focus on Abortion
  • Adding It Up
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Oceania
  • United States

Who We Are

  • About us
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Guttmacher Guardians
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • COVID-19 impact
  • Reproductive Health Impact Study
  • IPSRH: Focus on Abortion
  • Adding It Up
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Oceania
  • United States

Who We Are

  • About us
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Guttmacher Guardians
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship

Search form

As of April 1, 2021 State Laws and Policies

Partner Treatment for STIs

Background

In 2006, the Centers for Disease Control and Prevention (CDC) recommended that health care providers who treat patients for chlamydia and gonorrhea also provide treatment for the patient’s partner, even if he or she has not been seen by the provider. In response to this recommendation, several states have adopted laws and regulations to implement so-called expedited partner therapy (EPT). Most of these state policies follow the CDC guidelines and recommend this course of treatment for gonorrhea and chlamydia infections. In other cases, states allow EPT for the treatment of all STIs or only for specific infections, such as gonorrhea, chlamydia or trichomoniasis. Several of these states encourage or require the health care practitioner to provide information about STIs to the patient to give to their partner.

Visit our state legislation tracker for policy activity on all sexual and reproductive health topics.

Highlights

  • 38 states and the District of Columbia allow health care practitioners to provide at least some STI treatment for the partner of a patient diagnosed with an STI without first examining the partner.
    • 8 states allow treatment for all or most STIs.
    • 30 states and the District of Columbia permit treatment for specific STIs.
      • 30 states and the District of Columbia allow treatment for chlamydia.
      • 28 states and the District of Columbia allow treatment for gonorrhea.
      • 5 states and the District of Columbia permit treatment for trichomoniasis.
  • 15 states and the District of Columbia encourage or require health care practitioners to provide patients with information about STIs to give to their partner.
Printer-friendly version

For more information

  • Public Policy Office

    202 296-4012
    [email protected]

Topic

United States

  • HIV & STIs: STATE POLICIES ON HIV & STIs

Geography

  • United States: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming

Related Content

Policy Analysis

For Some Sexually Transmitted Infections, Secondary Prevention May Be Primary

Guttmacher Policy Review
Policy Analysis

Reducing STI Cases: Young People Deserve Better Sexual Health Information and Services

Guttmacher Policy Review

 

Expedited Partner  Therapy

STATE

PERMITS TREATMENT OF A PATIENT'S PARTNER FOR:

INFORMATION FOR A PATIENT'S PARTNER

All or Most STIs

Chlamydia

Gonorrhea

Trichomoniasis

Alaska

X

 

 

 

 

Arizona

X

 

 

 

 

Arkansas*

 

X

X

 

 

California

X

 

 

 

 

Colorado

X

 

 

 

 

Connecticut

 

X

X

 

 

Delaware†,‡​

 

X

X

 

Required 

District of Columbia

 

X

X

X

Required

Georgia

 

X

X

 

 

Hawaii

 

X

X

 

 

Idaho‡​

 

X

X

 

 

Illinois†​

 

X

X

 

Required

Indiana

 

X

X

 

Required

Iowa

 

X

X

 

 

Kentucky

 

X

X

 

 

Louisiana

 

X

X

 

Required

Maine†​

X

 

 

 

Required

Maryland

 

X

X

X 

 

Massachusetts

 

X

 

 

Encouraged

Michigan *,†​

 

X

X

 

 

Minnesota‡​

 

X

X

 

 

Missouri

 

X

X

 

 

Nebraska

 

X

X

X 

Required

Nevada‡​

 

X

X

 

 

New Hampshire

X

 

 

 

 

New Jersey*

 

X

X

 

 

New Mexico† 

 

X

X

X

Encouraged

New York

 

X

X 

 

Required

North Carolina‡​

 

X

X

 

 

North Dakota

X

 

 

 

 

Ohio

 

X

X

X

Required

Oregon†

 

X

X

 

Encouraged

Rhode Island

 

X

X

 

 

Tennessee†​

 

X

 

 

Required

Texas

X

 

 

 

 

Utah

 

X

X

 

 

Vermont

 

XΨ​

 X 

 

Required

Washington

 

X

X

 

Required 

West VirginaΩ,†​

 

 

 

 

 

Wisconsin

 

X

X

X

Required

TOTAL

8

30+DC

28+DC

5+DC

15+DC

*  State policy is limited to heterosexual partners.
† Allows treatment of a partner exposed to the infection in the 60 days before the patient was diagnosed.
‡  Requires providers to follow CDC guidelines, which recommend expedited partner treatment for the heterosexual partners of a patient with chlamydia and gonorrhea.
Ψ The state is developing regulations to expand partner therapy to additional conditions.
Ω The state is developing guidelines on conditions eligible for therapy.

 

Get updates on policy issues and more

Sign up for Guttmacher updates

Get the latest research and policy analyses on sexual and reproductive health and rights around the world.

Subscribe
Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2021 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get Our Updates